T Scott Stroup
Biographic Data
| ID | 5417828 |
|---|---|
| NAME | T Scott Stroup |
| GIVEN NAMES | T Scott |
| FAMILY NAME | Stroup |
| SIGNATURE | STROUP T S |
| AFFILIATIONS | Columbia University |
| ORCID | 0000-0002-3123-0672 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2003 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early Psychosis
Violence risk assessment for young adults receiving treatment for early psychosis
Deaths of people with mental illness during interactions with law enforcement
Premature Mortality Among Adults With Schizophrenia in the United States
In a US national cohort of adults with schizophrenia, excess deaths from cardiovascular and respiratory diseases implicate modifiable cardiovascular risk factors, including especially tobacco use. Excess deaths directly attributable to alcohol or other drugs highlight threats posed by substance abuse. More aggressive identification and management of cardiovascular risk factors, as well as reducing tobacco use and substance abuse, should be leadin…
Housing arrangements among a national sample of adults with chronic schizophrenia living in the United States
There has been no recent national description of where and with whom people with chronic mental illness reside. Using data from the Clinical Antipsychotic Trials of Intervention Effectiveness, the living arrangements of 1,446 clients with schizophrenia from 57 sites throughout the United States were characterized over 1 year. At baseline, 46% of participants were living with family members and loved ones, 5% were living with other nonrelatives, 1…
Criminal Justice System Involvement Among People with Schizophrenia
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
BACKGROUND: The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. We compared a first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study. METHODS: A total of 1493 patients with schizophrenia were recruited at 57 U.S. sites and randomly assigned to receive ol…
The Subject Advocate
Scott Stroup, Paul Appelbaum, The Subject Advocate: Protecting the Interests of Participants with Fluctuating Decisionmaking Capacity, IRB: Ethics & Human Research, Vol. 25, No. 3 (May - Jun., 2003), pp. 9-11
The Subject Advocate
Scott Stroup, Paul Appelbaum, The Subject Advocate: Protecting the Interests of Participants with Fluctuating Decisionmaking Capacity, IRB: Ethics & Human Research, Vol. 25, No. 3 (May - Jun., 2003), pp. 9-11
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
BACKGROUND: The relative effectiveness of second-generation (atypical) antipsychotic drugs as compared with that of older agents has been incompletely addressed, though newer agents are currently used far more commonly. We compared a first-generation antipsychotic, perphenazine, with several newer drugs in a double-blind study. METHODS: A total of 1493 patients with schizophrenia were recruited at 57 U.S. sites and randomly assigned to receive ol…
Criminal Justice System Involvement Among People with Schizophrenia
Housing arrangements among a national sample of adults with chronic schizophrenia living in the United States
There has been no recent national description of where and with whom people with chronic mental illness reside. Using data from the Clinical Antipsychotic Trials of Intervention Effectiveness, the living arrangements of 1,446 clients with schizophrenia from 57 sites throughout the United States were characterized over 1 year. At baseline, 46% of participants were living with family members and loved ones, 5% were living with other nonrelatives, 1…
Premature Mortality Among Adults With Schizophrenia in the United States
In a US national cohort of adults with schizophrenia, excess deaths from cardiovascular and respiratory diseases implicate modifiable cardiovascular risk factors, including especially tobacco use. Excess deaths directly attributable to alcohol or other drugs highlight threats posed by substance abuse. More aggressive identification and management of cardiovascular risk factors, as well as reducing tobacco use and substance abuse, should be leadin…
Deaths of people with mental illness during interactions with law enforcement
Violence risk assessment for young adults receiving treatment for early psychosis
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Feasibility and Utility of Different Approaches to Violence Risk Assessment for Young Adults Receiving Treatment for Early Psychosis
Medicine (6 works) · Psychiatry (6 works) · Schizophrenia research and treatment (6 works) · Psychology (4 works) · Healthcare Decision-Making and Restraints (3 works) · Injury prevention (3 works) · Internal Medicine (3 works) · Poison control (3 works) · Psychopathy, Forensic Psychiatry, Sexual Offending (3 works) · Schizophrenia (object-oriented programming) (3 works)